Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases

A systematic review of the literature

A. Molassiotis, G. Bryan, A. Caress, C. Bailey, J. Smith

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The management of cough in adults with respiratory and non-respiratory illnesses is suboptimal and based mostly on clinical opinions rather than evidence. A systematic review was carried out assessing all trials in adult patients with respiratory and non-respiratory diseases (excluding cancer) that had chronic cough as primary or secondary outcome. A total of 1177 trials were retrieved and 75 met the criteria for inclusion in the review. The vast majority were in patients with asthma and chronic obstructive pulmonary disease (COPD). Cough was the primary outcome in less than one-quarter of the studies. The measurement of cough was variable, mostly using unvalidated scales or being part of an overall 'symptoms' score. Positive results were overall seen with the use of corticosteroids, leukotriene receptor antagonists, mast cell stabilizers, ipratropium bromide, neltenexine, iodinised glycerol and lidocaine. Speech pathology training and symptom monitoring through SMS messages (accompanied by treatment adjustments) have also shown promise. Evidence for established anti-tussive agents such as codeine was scarce, with positive studies from the 1960s, whilst more recent studies showed no effect in patients with COPD. Many studies had conflicting results. It is imperative that the management of cough and its evidence base be improved, using higher quality research designs and with cough being the primary outcome of trials.

Original languageEnglish
Pages (from-to)199-206
Number of pages8
JournalRespiratory Medicine CME
Volume3
Issue number4
DOIs
Publication statusPublished - 7 Dec 2010
Externally publishedYes

Fingerprint

Cough
Pharmacology
Chronic Obstructive Pulmonary Disease
Speech-Language Pathology
Ipratropium
Leukotriene Antagonists
Codeine
Steroid Receptors
Lidocaine
Mast Cells
Glycerol
Research Design
Asthma
Neoplasms

Cite this

@article{52da2d4f09e5456aa9f11b193dfb53db,
title = "Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature",
abstract = "The management of cough in adults with respiratory and non-respiratory illnesses is suboptimal and based mostly on clinical opinions rather than evidence. A systematic review was carried out assessing all trials in adult patients with respiratory and non-respiratory diseases (excluding cancer) that had chronic cough as primary or secondary outcome. A total of 1177 trials were retrieved and 75 met the criteria for inclusion in the review. The vast majority were in patients with asthma and chronic obstructive pulmonary disease (COPD). Cough was the primary outcome in less than one-quarter of the studies. The measurement of cough was variable, mostly using unvalidated scales or being part of an overall 'symptoms' score. Positive results were overall seen with the use of corticosteroids, leukotriene receptor antagonists, mast cell stabilizers, ipratropium bromide, neltenexine, iodinised glycerol and lidocaine. Speech pathology training and symptom monitoring through SMS messages (accompanied by treatment adjustments) have also shown promise. Evidence for established anti-tussive agents such as codeine was scarce, with positive studies from the 1960s, whilst more recent studies showed no effect in patients with COPD. Many studies had conflicting results. It is imperative that the management of cough and its evidence base be improved, using higher quality research designs and with cough being the primary outcome of trials.",
keywords = "Asthma, Bronchitis, COPD, Cough, Respiratory disease, Systematic review",
author = "A. Molassiotis and G. Bryan and A. Caress and C. Bailey and J. Smith",
year = "2010",
month = "12",
day = "7",
doi = "10.1016/j.rmedc.2010.11.001",
language = "English",
volume = "3",
pages = "199--206",
journal = "Respiratory Medicine Case Reports",
issn = "2213-0071",
publisher = "Elsevier BV",
number = "4",

}

Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases : A systematic review of the literature. / Molassiotis, A.; Bryan, G.; Caress, A.; Bailey, C.; Smith, J.

In: Respiratory Medicine CME, Vol. 3, No. 4, 07.12.2010, p. 199-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases

T2 - A systematic review of the literature

AU - Molassiotis, A.

AU - Bryan, G.

AU - Caress, A.

AU - Bailey, C.

AU - Smith, J.

PY - 2010/12/7

Y1 - 2010/12/7

N2 - The management of cough in adults with respiratory and non-respiratory illnesses is suboptimal and based mostly on clinical opinions rather than evidence. A systematic review was carried out assessing all trials in adult patients with respiratory and non-respiratory diseases (excluding cancer) that had chronic cough as primary or secondary outcome. A total of 1177 trials were retrieved and 75 met the criteria for inclusion in the review. The vast majority were in patients with asthma and chronic obstructive pulmonary disease (COPD). Cough was the primary outcome in less than one-quarter of the studies. The measurement of cough was variable, mostly using unvalidated scales or being part of an overall 'symptoms' score. Positive results were overall seen with the use of corticosteroids, leukotriene receptor antagonists, mast cell stabilizers, ipratropium bromide, neltenexine, iodinised glycerol and lidocaine. Speech pathology training and symptom monitoring through SMS messages (accompanied by treatment adjustments) have also shown promise. Evidence for established anti-tussive agents such as codeine was scarce, with positive studies from the 1960s, whilst more recent studies showed no effect in patients with COPD. Many studies had conflicting results. It is imperative that the management of cough and its evidence base be improved, using higher quality research designs and with cough being the primary outcome of trials.

AB - The management of cough in adults with respiratory and non-respiratory illnesses is suboptimal and based mostly on clinical opinions rather than evidence. A systematic review was carried out assessing all trials in adult patients with respiratory and non-respiratory diseases (excluding cancer) that had chronic cough as primary or secondary outcome. A total of 1177 trials were retrieved and 75 met the criteria for inclusion in the review. The vast majority were in patients with asthma and chronic obstructive pulmonary disease (COPD). Cough was the primary outcome in less than one-quarter of the studies. The measurement of cough was variable, mostly using unvalidated scales or being part of an overall 'symptoms' score. Positive results were overall seen with the use of corticosteroids, leukotriene receptor antagonists, mast cell stabilizers, ipratropium bromide, neltenexine, iodinised glycerol and lidocaine. Speech pathology training and symptom monitoring through SMS messages (accompanied by treatment adjustments) have also shown promise. Evidence for established anti-tussive agents such as codeine was scarce, with positive studies from the 1960s, whilst more recent studies showed no effect in patients with COPD. Many studies had conflicting results. It is imperative that the management of cough and its evidence base be improved, using higher quality research designs and with cough being the primary outcome of trials.

KW - Asthma

KW - Bronchitis

KW - COPD

KW - Cough

KW - Respiratory disease

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=78649963273&partnerID=8YFLogxK

U2 - 10.1016/j.rmedc.2010.11.001

DO - 10.1016/j.rmedc.2010.11.001

M3 - Article

VL - 3

SP - 199

EP - 206

JO - Respiratory Medicine Case Reports

JF - Respiratory Medicine Case Reports

SN - 2213-0071

IS - 4

ER -